Kingsley R. Chin MD MBA, CEO Spine Surgeon Professor Author’s Post

Understanding proper CPT coding is crucial for accurate billing and practice protection. CPT 22612 specifically applies to lumbar fusion with posterolateral bone graft. Placing bone graft inside a metal device may not fully align with this code. To clarify the coding and technique, check out the informative video by NANISX. Staying informed helps ensure compliance and avoids potential billing issues. Learn More: www.KICVentures.com www.NANISX.com #MedicalBilling #CPT22612 #SpineSurgery #Compliance #PatientCare Kingsley R. Chin MD MBA, CEO Spine Surgeon Professor Author Taylor Headley Erik Spayde, MD

Long-term findings from a prospective randomised controlled trial, with a twenty-year follow-up, reveal that Cervical Disk Arthroplasty preserves both index-level and total cervical Range Of Motion (ROM) at the 20-year mark, maintaining values similar to those observed immediately postoperatively. Reference: D. P. Foley et al., “Twenty-Year Radiographic Outcomes Following Single-Level Cervical Disc Arthroplasty: Results from a Prospective Randomized Controlled Trial,” Spine (Phila Pa 1976), vol. 49, no. 5, pp. 295–303, 2024, doi: 10.1097/BRS.0000000000004888. #SouthernMedical #ImplantPerfection #SouthAfrican #Manufacturer #Biotechnology #spineimplants #spinesurgery #spine

Vertebral Compression Fracture Treatment Enhanced by Medtronic and Merit Medical Systems, Inc. Collaboration Medtronic and Merit Medical Systems, Inc. have partnered to distribute the Kyphon KyphoFlex unipedicular balloon catheter in the U.S., enhancing vertebral compression fracture (VCF) treatments. The Kyphon KyphoFlex catheter, designed for precise cavity creation using orthopedic balloons, treats VCFs caused by osteoporosis, cancer, or benign lesions. Medtronic will handle sales and marketing, while Merit Medical Systems, Inc. oversees manufacturing and regulatory compliance. This collaboration leverages the strengths of both companies to provide a steerable solution for targeted vertebral augmentation, aiming to improve patient outcomes and quality of life. For more details please click the link! https://lnkd.in/greG5yhE #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical 

A meta-analysis comparing outcomes of expandable Lumbar interbody fusion (LIF) cages with static cages, indicated a numerically longer operative time for MIS-LIF procedures using expandable cages (MD 184 minutes, 95% CI 133.6–234.4) versus static cages (MD 150.4 minutes, 95% CI 139.4–161.4). However, this difference was not statistically significant, indicating similar overall surgical efficiency [8] Reference P. Calvachi-Prieto et al., “Expandable Versus Static Cages in Minimally Invasive Lumbar Interbody Fusion: A Systematic Review and Meta-Analysis,” World Neurosurg, vol. 151, pp. e607–e614, 2021, doi: 10.1016/j.wneu.2021.04.090. #SouthernMedical #ImplantPerfection #SouthAfrican #Manufacturer #Biotechnology #spineimplants #spinesurgery #spine

Redefining Medical Innovation: EPO's Bold Move on 'Substance or Composition' 🌟 The EPO's recent decision, T 1252/20, marks a pivotal shift in the definition of 'substance or composition' for medical use claims. Moving away from the traditional emphasis on chemical activity, this ruling embraces a broader interpretation, including materials that achieve therapeutic effects through physical properties. This groundbreaking change paves the way for innovative medical solutions, such as hydrogels for blocking biological vessels, to be recognized under patent law. It signifies a leap forward in supporting diverse medical technologies, from diagnostics to surgery, fostering further innovation in healthcare. More on the topic - https://lnkd.in/eseCM8eQ #EPO #MedicalInnovation #PatentLaw #HealthcareTech

A meta-analysis comparing fusion rates in minimally invasive lumbar interbody fusion (MIS-LIF) with expandable versus static cages found the mean fusion rates were similar for both expandable cages (MD 0.94, 95% CI 0.91–0.96) and static cages (MD 0.92, 95% CI 0.87–0.96) across the included studies [8] Reference: (8) P. Calvachi-Prieto et al., “Expandable Versus Static Cages in Minimally Invasive Lumbar Interbody Fusion: A Systematic Review and Meta-Analysis,” World Neurosurg, vol. 151, pp. e607–e614, 2021, doi: 10.1016/j.wneu.2021.04.090. #SouthernMedical #ImplantPerfection #SouthAfrican #Manufacturer #Biotechnology #spineimplants #spinesurgery #spine

#Pterygium is a benign fibrovascular growth that extends from the conjunctiva to the corneal surface that can cause eye irritation, redness and impair vision. It most often affects people exposed to high levels of ultraviolet light or certain other environmental factors during outdoor work or leisure activities.      While there are no FDA-approved drugs for pterygium, Cloudbreak is developing the first potential therapy for this condition, which is now in Phase 3 clinical trials. Learn more about our work:  https://lnkd.in/e_UnxjTr

The 20-year follow-up study by Foley et al. showed that adjacent level disc heights were better preserved in patients with cervical disc arthroplasty (CDA) compared to those with anterior cervical discectomy and fusion (ACDF). Decreased disc height was significantly more pronounced in the ACDF group at both superior and inferior adjacent levels (P=0.032; P=0.008), suggesting better long-term outcomes with CDA. Reference: D. P. Foley et al., “Twenty-Year Radiographic Outcomes Following Single-Level Cervical Disc Arthroplasty: Results from a Prospective Randomized Controlled Trial,” Spine (Phila Pa 1976), vol. 49, no. 5, pp. 295–303, 2024, doi: 10.1097/BRS.0000000000004888. #SouthernMedical #ImplantPerfection #SouthAfrican #Manufacturer #Biotechnology #spineimplants #spinesurgery #spine

Considering PuraBond for tonsillectomy? Download our overview to find out how it is useful for this specific procedure and how other surgeons have found using PuraBond. https://hubs.li/Q02ThxBT0 #3dmatrix #purabond #ENT #tonsillectomy #patientoutcomes #bleedmanagement #hydrogel #peptides

𝐄𝐥𝐞𝐜𝐭𝐫𝐨𝐬𝐮𝐫𝐠𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐖𝐨𝐫𝐭𝐡 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $𝟗.4 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟗 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐚𝐭- https://lnkd.in/d9MUqDJq The global electrosurgery market in terms of revenue was estimated to be worth $6.9 billion in 2024 and is poised to reach $9.4 billion by 2029, growing at a CAGR of 6.4% from 2024 to 2029. 𝐤𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 Medtronic Plc Johnson & Johnson Olympus Corporation B. Braun Group CONMED Corporation Boston Scientific Smith+Nephew Erbe Elektromedizin GmbH Stryker BOWA-electronic KG THE COOPER COMPANIES GLOBAL HOLDINGS LP Kirwan Surgical Products LLC Zimmer Biomet Utah Medical Products, Inc. Integra LifeSciences Holdings SAS Encision KLS Martin Group Surgical Holdings I.C. Medical Meyer-Haake GmbH - Medical Innovations Aspen Surgical Applied Medical Resources Apyx Medical DirectaDentalGroup